MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0389416
Emerging Pharmaceuticals Private Limited
Emerging Pharmaceuticals Private Limited - chemicals in Beed, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹79.03 Lakh
▲ 14% YoY
Net profit · FY 2024
₹66,097
Net margin 0.8%
EBITDA · FY 2024
₹99,260
EBITDA margin 1.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Emerging Pharmaceuticals Private Limited
Data last updated:
Emerging Pharmaceuticals Private Limited is a private limited company based in Beed, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 24 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2014PTC256510. Its GSTIN is 27AADCE7405M1ZF (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pawankumar Sandipan Kakade and Sonali Balu Kale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.N.1.3.587 Mitra Nagar, Beed, Maharashtra, India – 431122.
As per the financials filed for FY 2024, the company reported a revenue of ₹79.03 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹66,097 (net margin 0.8%) and EBITDA of ₹99,260 (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 71% over five years.
Emerging Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0389416). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74120MH2014PTC256510
Registration Number 256510
Incorporation Date 24 July 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0389416
Recognitions & Rankings of Emerging Pharmaceuticals
Contact details
Emerging Pharmaceuticals Private Limited's registered office is in Beed, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.N.1.3.587 Mitra Nagar, Beed, Maharashtra, India – 431122
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Emerging Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Emerging Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Emerging Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Emerging Pharmaceuticals Private Limited, buy the company report.
Financials of Emerging Pharmaceuticals Private Limited
FY 2025 filings availableEmerging Pharmaceuticals Private Limited reported revenue of ₹79.03 Lakh (up 14% YoY) for FY 2024.
Revenue · FY 2024
₹79.03 Lakh ▲ 14%
Net profit · FY 2024
₹66,097 margin 0.8%
EBITDA · FY 2024
₹99,260 margin 1.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 36%
5 years · compounded
▲ 71%
EBITDA CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 39%
5 years · compounded
▲ 47%
Revenue has grown at a compounded annual rate (CAGR) of 71% over five years, including 14% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹99,260 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹66,097 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emerging Pharmaceuticals Private Limited, buy the company report.
Board of directors of Emerging Pharmaceuticals Private Limited
Emerging Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawankumar Sandipan Kakade | Director | 24 Jul 2014 | 12 Years 3 Months | Current |
| Sonali Balu Kale Also directs: Shaurya Foods and Dairy Products LLP | Additional Director | 05 Jan 2026 | 0 Years 9 Months | Current |
Auditor
Emerging Pharmaceuticals Private Limited is audited by AVTARSINGH SAINI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AVTARSINGH SAINI | FY 2017 | 140512 |
Shareholding
The shareholding of Emerging Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Emerging Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Emerging Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emerging Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Emerging Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCE7405M1ZF | Maharashtra | Active | 09 Aug 2017 |
To see the full GST registrations and return filing status of Emerging Pharmaceuticals Private Limited, buy the company report.
Recent activity
Emerging Pharmaceuticals Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Devidas Murlidhar Jogdand ceased to be Director on 05 Jan 2026.
Ceased
Devidas Murlidhar Jogdand ceased to be Director.
Appointed
Sonali Balu Kale was appointed as Additional Director.
AGM
Emerging Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Emerging Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Devidas Murlidhar Jogdand was appointed as Director.
Appointed
Pawankumar Sandipan Kakade was appointed as Director.
Incorporation
24 Jul 2014
Emerging Pharmaceuticals Private Limited was registered on 24 Jul 2014 with Roc Mumbai & aged 12 years 3 months as per MCA records.
Frequently asked questions
Emerging Pharmaceuticals is an active private limited company based in Beed, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 24 July 2014 (12+ years old) and is registered under CIN U74120MH2014PTC256510.
Emerging Pharmaceuticals has 2 current directors:
- Pawankumar Sandipan Kakade - Director
- Sonali Balu Kale - Additional Director
The latest financial statements of Emerging Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Emerging Pharmaceuticals is 27AADCE7405M1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Emerging Pharmaceuticals is U74120MH2014PTC256510. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emerging Pharmaceuticals was incorporated on 24 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Devidas Murlidhar Jogdand ceased to be Director on 05 Jan 2026. Sonali Balu Kale was appointed as Additional Director on 05 Jan 2026. Devidas Murlidhar Jogdand was appointed as Director on 24 Jul 2014. Emerging Pharmaceuticals has 4 board changes on record in total.
Yes, Emerging Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0389416).
The registered office of Emerging Pharmaceuticals is at H.N.1.3.587 Mitra Nagar, Beed, Maharashtra, India – 431122.
Emerging Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.